NJ S2247

Requires all hospitals, birthing centers, federally qualified health centers, and healthcare providers in New Jersey to offer non-invasive prenatal testing (NIPT) to every pregnant person, with testing available starting at 10 weeks of pregnancy to screen for Down syndrome and other chromosomal abnormalities.

Mandates that all health insurers—including commercial insurers, HMOs, State Health Benefits Program, School Employees' Health Benefits Program, and Medicaid—cover NIPT expenses at the same level as any other medical condition.

Healthcare providers must educate pregnant persons about chromosomal abnormalities and testing benefits, and testing is required unless the person provides written refusal on a standardized form developed by the Commissioner of Health.

Positive test results must be discussed with the patient, who will then be referred to a genetic counselor for further consultation.

Takes effect on the first day of the fourth month following enactment, with testing methods to follow the most recent guidelines from the American College of Obstetricians and Gynecologists.